View Cart
Global Information, Inc.
US:
+1-860-674-8796
EU:
+32-2-535-7543
SG:
+65-6223-2436
Home
|
Category
|
Publishers
|
Custom Research
|
E-mail Alert
|
About Us
|
Contact Us
|
Site Map
|
Biotechnology
Antibody & Immunity
Biomaterials
Gene Therapeutics & RNAi
Regenerative Medicine
Molecular Targeted Therapeutics
Genome-based Drug Discovery
Biomarker
Biotechnology Equipment
Personalized Medicine
View All Categories
Home
>
Category
>
Biotechnology
>
Market Research Report
Multiplexed Diagnostics 2008 Market Report
Published by
Select Biosciences, Ltd.
Published
2008/05
Content info
260 pages
Product code
SB69333
Price
From
US $ 3550
US $ 3550
Hard Copy
US $ 4170
PDF by E-mail (Site License)
How to Order?
PDF by E-Mail
Approx. 1-2 business days
Hard Copy/CD-ROM
Approx. 3-4 business days
If you need expedited delivery, please call us.
Table of Contents
Chapter 1: Executive Summary
The Wild West of Medicine
Opportunities and Strategies
The Opportunity is Significant
Rapidly Advancing Technology
Barriers Broken Down
Major Unmet Needs
New Biomarkers
Strategy is Critical
Compensation
Competition
Regulation
Education
Summary of Market Drivers
Market Model
Chapter 2: Introduction to Multiplexing
Why Multiplex?
Independent Tests Versus Multivariate
Multivariate Tests
The Potential Versus the Reality
Successes and Challenges
Technologies for Multiplexing
Introduction
Platforms
Platforms - Luminex
Chapter 3: Regulatory Hurdles
To Regulate or Not To Regulate
United States (FDA)
Draft Guidance for IVDMIA
Retrospective Versus Prospective
Current Guidelines Are Hazy
The FDA May Not Be Up to the Task
Europe
IVD
Potential Pitfalls
Chapter 4: Market Drivers
The Wild West of Medicine
Unmet Needs
Diagnosis
Responses to Treatment
Discovery of New Biomarkers
Genome-Wide Association Studies
Introduction and Successes
Limitations
Copy Number Variation
Protein Biomarkers
Metabolic Biomarkers
The Next Generation
MicroRNAs
Comparative Genomics By Sequence Analysis
Integration of Different Types of Data
Tissue Availability
Tissue Specificity
General Screening Versus Proprietary Markers
New Development Has Widespread Support
Not Everyone Is Convinced of the Value
Insurance Is A Problem
Education
Business Models
Insurance Versus Direct Payment
Getting Reimbursement Is Difficult
Competitive Environment
Competition Reigns
Differentiation Amidst Complexity
Looking Into the Future
Chapter 5: Market Survey
Methodology
Participants
Question 1
Total
By Category
Question 2
Total
By Category
Question 3
Total
By Category
Question 4
Total
By Category
Question 5
Total
By Category
Question 6
Total
By Category
Question 7
Total
By Category
Question 8
Total
By Category
Question 9
Total
By Category
Question 10
Total
By Category
Question 11
Total
By Category
Question 12
Total
By Category
Question 13
Total
By Category
By Open Response
Question 14
Total
By Category
Chapter 6: Market Model
Introduction and Methodology
Summary of Market Drivers
Market Model
Chapter 7: Multiplexed Diagnostics on the Market
Introduction
Allergies
Autoimmune
Blood
Cancer
Cardiac
Drug Metabolism
Drugs of Abuse
Genetic
Infectious Disease
Metabolic
Neurologic
Ophthalmic
Prenatal
Psychiatric
Typing
Chapter 8: Multiplexed Diagnostics In Development
Introduction
Autoimmune
Blood
Cancer
Cardiac
Genetic
Infectious Disease
Metabolic
Neurologic
Psychiatric
Related Report
Innovations in Oncology Diagnostics: Technological advances, growth opportunities and future market outlook
The Market Outlook for Research Products in FY2010
A Worldwide Overview of the Coagulation Testing Market: Facilities, Test Volumes, and Sales Forecasts for Reagents and Instruments by Country
Assessment of the Molecular Diagnostic Market for 44 NA Tests in France
Assessment of the Molecular Diagnostic Market for 44 NA Tests in Germany
Please inform me when related publications are released
US: 1-860-674-8796 EU: 32-2-535-7543 SG: 65-6223-2436
The vertical markets research portal
© 2009, the-infoshop.com by Global Information, Inc. All rights reserved.